Search by Drug Name or NDC

    NDC 49702-0202-18 COMBIVIR 150; 300 mg/1; mg/1 Details

    COMBIVIR 150; 300 mg/1; mg/1

    COMBIVIR is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ViiV Healthcare Company. The primary component is LAMIVUDINE; ZIDOVUDINE.

    Product Information

    NDC 49702-0202
    Product ID 49702-202_9c13ddca-9cd4-4460-a16a-68da944ab01d
    Associated GPIs 12109902500320
    GCN Sequence Number 034186
    GCN Sequence Number Description lamivudine/zidovudine TABLET 150-300 MG ORAL
    HIC3 W5L
    HIC3 Description ANTIVIRALS, HIV-SPEC., NUCLEOSIDE ANALOG, RTI COMB
    GCN 89621
    HICL Sequence Number 014014
    HICL Sequence Number Description LAMIVUDINE/ZIDOVUDINE
    Brand/Generic Brand
    Proprietary Name COMBIVIR
    Proprietary Name Suffix n/a
    Non-Proprietary Name lamivudine and zidovudine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 150; 300
    Active Ingredient Units mg/1; mg/1
    Substance Name LAMIVUDINE; ZIDOVUDINE
    Labeler Name ViiV Healthcare Company
    Pharmaceutical Class Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleosi
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020857
    Listing Certified Through 2024-12-31

    Package

    NDC 49702-0202-18 (49702020218)

    NDC Package Code 49702-202-18
    Billing NDC 49702020218
    Package 60 TABLET, FILM COATED in 1 BOTTLE (49702-202-18)
    Marketing Start Date 2010-10-19
    NDC Exclude Flag N
    Pricing Information N/A